Using HeLa cells and two lung-cancer cell lines, the authors showed that CBP and p300 physically bind to the promoter regions of both these genes, but also affect acetylation of histones H3 and H4, which led to insufficient binding of transcription factors. This evidence concerns the gene EP300 and lung cancer.